Concepedia

Breeze E. Cavell

BE

Statistics

Publications

21

Citations

1.3K

H-Index

17

Active since

2009

Affiliations

Public Health England(Current)

University of Oxford

University of Southampton

Cancer Research UK

Centre for Human Genetics

Breeze E. Cavell is an author at Public Health England specializing in infectious diseases, immunology, and vaccination.

ORCID

Publications per year

2009–2025

21

Publications

21

Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses

Jordan R. Barrett, Sandra Belij‐Rammerstorfer, Christina Dold et al. · Nature Medicine · 2020 · 340 citations · Full text

, , +12

Dose-dependent response to infection with SARS-CoV-2 in the ferret model and evidence of protective immunity

Kathryn A. Ryan, Kevin R. Bewley, Susan Fotheringham et al. · Nature Communications · 2021 · 185 citations · Full text

, , +17

Comparison of rhesus and cynomolgus macaques as an infection model for COVID-19

Francisco J. Salguero, Andrew White, Gillian S. Slack et al. · Nature Communications · 2021 · 166 citations · Full text

, , +17

Prophylactic intranasal administration of a TLR2/6 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model

Pamela C. Proud, Daphne Tsitoura, Robert J. Watson et al. · EBioMedicine · 2020 · 93 citations · Full text

, , +17

Immunogenicity and safety of BPZE1, an intranasal live attenuated pertussis vaccine, versus tetanus–diphtheria–acellular pertussis vaccine: a randomised, double-blind, phase 2b trial

Cheryl Keech, Vicki E. Miller, Barbara Rizzardi et al. · The Lancet · 2023 · 60 citations

, , +12

1–5 of 21